Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients

Autoimmunity

Volumn 44, Issue 7, 2011, Pages 543-548

  Muoz Espinosa, Linda ^a   Alarcon, Gabriela ^a   Mercado Moreira, Amanda ^a   Cordero, Paula ^a   Caballero, Eloy ^a   Avalos, Victor ^a   Villarreal, Gregorio ^a   Senties, Karla ^a   Puente, David ^a   Soto, Jorge ^a   Esqueda, Brenda ^a   Campos, Gina ^a   Martnez, Manuel ^a   Jaquez, Joel ^a   Ramirez, Angel ^a   Reyes, Itzel ^a   Kershenobich, David ^b   Montano Loza, Aldo J ^c  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autoimmune liver disease; Definite diagnosis; Hispanics; Probable diagnosis; Revised scoring system; Simplified scoring system

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; INTERNATIONAL AUTOIMMUNE HEPATITIS GROUP; MALE; MEXICO; PREDICTIVE VALUE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLASSIFICATION; COHORT STUDIES; FEMALE; HEPATITIS, AUTOIMMUNE; HISPANIC AMERICANS; HUMANS; MALE; MEXICO; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80053998101     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.592884     Document Type: Article

References (37)

1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18: 998-1005.
2. Alvarez F, Berg PA, Bianchi FB, Burroughs AK, Cancado EL, Chapman RW, CooksleyWG, Czaja AJ,Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zumBus̈chenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938. (Pubitemid 29514229)
3. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176. (Pubitemid 351975541)
4. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008;48: 1540-1548.
5. Choi G, Peters MG. The challenge of diagnosing autoimmune hepatitis: Less is more. Hepatology 2008;48:10-12. (Pubitemid 351975525)
6. Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009;50:538-545.
7. Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology 2009;49:1782-1783.
8. Qiu D,Wang Q,Wang H, Xie Q, Zang G, Jiang H, Tu C, Guo J, Zhang S, Wang J, Lu Y, Han Y, Shen L, Chen X, Hu X, Wang X, Chen C, Fu Q, Ma X. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011;54:340-347.
9. Wiegard C, Schramm C, Lohse AW. Scoring systems for the diagnosis of autoimmune hepatitis: Past, present, and future. Semin Liver Dis 2009;29:254-261.
10. Czaja AJ. Special clinical challenges in autoimmune hepatitis: The elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis 2009;29:315-330.
11. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007;46:1828-1835.
12. Beland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.World J Gastroenterol 2009;15:1025-1034.
13. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigensDR4and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-706.
14. Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig Dis Sci 2002;47:2139-2150. (Pubitemid 35205286)
15. Feld JJ, Heathcote EJ. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol 2003;18:1118-1128. (Pubitemid 37410040)
16. Montano-Loza AJ, Carpenter HA, Czaja AJ. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis. Liver Int 2006;26:1201-1208. (Pubitemid 44741207)
17. Vazquez-García MN, Alaez C, Olivo A, Debaz H, Pérez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernández A, Bandera J, Torres LF, Kershenobich D, Alvarez F, Gorodezky C. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 1998;28:985-990. (Pubitemid 28275977)
18. Bittencourt P, Goldberg A, Cancado E, Porta G, Carrilho F, Farias A, Palacios S, Ciarella J, Abrantes C, Baggio V, Laudanna A, Kalil J. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999; 94:1907-1913.
19. Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 2002;37:302-308. (Pubitemid 34969945)
20. Fortes M, Machado I, Gil G, Fernández M, Dagher L, Leoń R, Bianco N, Tassinari P. Genetic contribution of major histocompatibility complex class II region to type1autoimmune hepatitis susceptibility in Venezuela. Liver Int 2007;27: 1409-1416. (Pubitemid 350142256)
21. Pando M, Larriba J, Fernandez G, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Cañero C, Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition. Hepatology 1999;30:137-180.
22. Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology 1984;4:622-627. (Pubitemid 14051128)
23. Brunt EM, Ramrakhiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, di Bisceglie AM. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 2003;16:49-56. (Pubitemid 36152686)
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321. (Pubitemid 40770284)
25. Heathcote E. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005-1013.
26. Chazouilleres O, Wenhdum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosisautoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998;28:296-301. (Pubitemid 28363652)
27. Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30:394-401. (Pubitemid 29113226)
28. Mehendiratta V, Mitroo P, Bombonati A, Navarro VJ, Rossi S, Rubin R, Herrine SK. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2009;7: 98-103.
29. Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: Presenting features and response to therapy. Am J Gastroenterol 2001;96:3390-3394. (Pubitemid 34016665)
30. Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002;50:713-717. (Pubitemid 34407503)
31. Flores YN, Yee HF, Jr, Leng M, Escarce JJ, Bastani R, Salmeroń J, Morales LS. Risk factors for chronic liver disease in Blacks. Mexican Americans, and Whites in the United States: Results from NHANES IV, 1999-2004. Am J Gastroenterol 2008;103:2231-2238.
32. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000;174:250-259. (Pubitemid 30201393)
33. Czaja AJ, Carpenter HA, Moore SB, Clinical LA. phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4. Liver Int 2006;26:552-558.
34. Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIHPBC) from those with auto-immune hepatitis type 1? Ann Hepatol 2011;10:28-32.
35. Zepeda-Gomez S, Montaño-Loza A, Zapata-Colindres JC, Paz F, Olivera-Martinez M, Loṕez-Reyes A, Granados J, Vargas-Alarcoń G. HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes. Immunol Invest 2009;38:276-283.
36. Gorodezky C, Alaez C, Vázquez-García MN, de la Rosa G, Infante E, Balladares S, Toribio R, Pérez-Luque E, Muñoz L. The genetic structure of Mexican Mestizos of different locations: Tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001;62:979-991. (Pubitemid 32835062)
37. Lindor RA, Lindor KD. The value of observational research in liver diseases. Hepatology 2011;53:1-3.